(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash, cash equivalents and federal funds sold | 141.14%11.95M | 141.14%11.95M | -77.19%4.95M | -77.19%4.95M | 98.61%21.71M | 98.61%21.71M | 18.97%10.93M | 18.97%10.93M | -34.30%9.19M | -34.30%9.19M |
-Cash and cash equivalents | 141.14%11.95M | 141.14%11.95M | -77.19%4.95M | -77.19%4.95M | 98.61%21.71M | 98.61%21.71M | 18.97%10.93M | 18.97%10.93M | -34.30%9.19M | -34.30%9.19M |
Long term equity investment | 13.13%386.2M | 13.13%386.2M | 11.32%341.36M | 11.32%341.36M | -17.54%306.64M | -17.54%306.64M | 37.92%371.87M | 37.92%371.87M | 6.40%269.62M | 6.40%269.62M |
Receivables | -2.16%1.36M | -2.16%1.36M | -30.42%1.39M | -30.42%1.39M | -39.91%1.99M | -39.91%1.99M | 361.06%3.32M | 361.06%3.32M | -75.98%719K | -75.98%719K |
-Accounts receivable | -2.16%1.36M | -2.16%1.36M | -30.42%1.39M | -30.42%1.39M | -39.91%1.99M | -39.91%1.99M | 361.06%3.32M | 361.06%3.32M | -75.98%719K | -75.98%719K |
Deferred assets | ---- | ---- | --786K | --786K | ---- | ---- | ---- | ---- | -89.78%14K | -89.78%14K |
Total assets | 14.64%399.5M | 14.64%399.5M | 5.49%348.49M | 5.49%348.49M | -14.44%330.35M | -14.44%330.35M | 38.12%386.11M | 38.12%386.11M | 3.34%279.54M | 3.34%279.54M |
Liabilities | ||||||||||
Derivative product liabilities | -38.08%161K | -38.08%161K | 333.33%260K | 333.33%260K | 27.66%60K | 27.66%60K | --47K | --47K | ---- | ---- |
Payables | -37.59%88K | -37.59%88K | -87.10%141K | -87.10%141K | 1,216.87%1.09M | 1,216.87%1.09M | -52.57%83K | -52.57%83K | 1.16%175K | 1.16%175K |
-Accounts payable | -37.59%88K | -37.59%88K | -87.10%141K | -87.10%141K | 1,216.87%1.09M | 1,216.87%1.09M | -52.57%83K | -52.57%83K | 1.16%175K | 1.16%175K |
Current deferred liabilities | 140.21%687K | 140.21%687K | -97.21%286K | -97.21%286K | 82.68%10.24M | 82.68%10.24M | 406.32%5.61M | 406.32%5.61M | 30.08%1.11M | 30.08%1.11M |
Non current deferred liabilities | 57.01%43.33M | 57.01%43.33M | 53.43%27.6M | 53.43%27.6M | -60.06%17.99M | -60.06%17.99M | 92.76%45.04M | 92.76%45.04M | 12.77%23.36M | 12.77%23.36M |
Total liabilities | 56.51%44.27M | 56.51%44.27M | -3.73%28.28M | -3.73%28.28M | -42.13%29.38M | -42.13%29.38M | 106.01%50.77M | 106.01%50.77M | 7.34%24.65M | 7.34%24.65M |
Shareholders'equity | ||||||||||
Share capital | 1.47%227.1M | 1.47%227.1M | 0.91%223.82M | 0.91%223.82M | 6.13%221.8M | 6.13%221.8M | 10.24%208.99M | 10.24%208.99M | 1.83%189.58M | 1.83%189.58M |
-common stock | 1.47%227.1M | 1.47%227.1M | 0.91%223.82M | 0.91%223.82M | 6.13%221.8M | 6.13%221.8M | 10.24%208.99M | 10.24%208.99M | 1.83%189.58M | 1.83%189.58M |
Retained earnings | 19.82%26.51M | 19.82%26.51M | 51.87%22.12M | 51.87%22.12M | 54.10%14.57M | 54.10%14.57M | -1.08%9.45M | -1.08%9.45M | 92.45%9.56M | 92.45%9.56M |
Gains losses not affecting retained earnings | 36.85%101.63M | 36.85%101.63M | 14.95%74.26M | 14.95%74.26M | -44.74%64.6M | -44.74%64.6M | 109.66%116.9M | 109.66%116.9M | -1.17%55.76M | -1.17%55.76M |
Total stockholders'equity | 10.94%355.23M | 10.94%355.23M | 6.39%320.2M | 6.39%320.2M | -10.25%300.97M | -10.25%300.97M | 31.56%335.34M | 31.56%335.34M | 2.97%254.9M | 2.97%254.9M |
Total equity | 10.94%355.23M | 10.94%355.23M | 6.39%320.2M | 6.39%320.2M | -10.25%300.97M | -10.25%300.97M | 31.56%335.34M | 31.56%335.34M | 2.97%254.9M | 2.97%254.9M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
No Data